Related Experiment Video
Updated: Jul 11, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Human papillomavirus and cervical cancer
Mark Schiffman1, Philip E Castle, Jose Jeronimo
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. schiffmm@mail.nih.gov
Human papillomavirus (HPV) causes nearly all cervical cancers. Understanding HPV genotypes and their role in cervical cancer progression is key to developing effective prevention and screening strategies worldwide.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Cervical cancer is a significant global health issue, predominantly caused by persistent human papillomavirus (HPV) infections.
- The pathogenesis involves a multi-step process from initial infection to invasive cancer.
Purpose of the Study:
- To elucidate the role of HPV genotypes in cervical carcinogenesis.
- To highlight the importance of an HPV-oriented model for understanding and managing cervical cancer.
- To emphasize the potential of HPV-related technologies for prevention and control.
Main Methods:
- Review and synthesis of current knowledge on HPV infection and cervical cancer development.
- Analysis of the multi-step progression model of cervical carcinogenesis.
- Evaluation of the impact of HPV genotypes on cancer risk.
Main Results:
- Persistent infection with specific carcinogenic HPV genotypes is the primary cause of cervical cancer.
- Cervical cancer development follows a defined pathway: infection, persistence, precancer, and invasion.
- Different HPV genotypes exhibit varying carcinogenic potentials.
Conclusions:
- An HPV-centric understanding of cervical carcinogenesis is crucial and should supersede older morphological models.
- Improved screening tests and vaccines targeting HPV have enhanced prevention and management.
- HPV-related technologies offer a promising strategy to reduce cervical cancer incidence, morbidity, and mortality globally, even in resource-limited settings.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
